Latest Biotech News

Recent studies spotlight advances in enzyme applications: Near-infrared spectroscopy streamlines quantitation of polysorbate surfactants critical to biologic formulations, addressing challenges in...

The U.S. Food and Drug Administration granted expedited approval to the combination of Jazz Pharmaceuticals' Zepzelca (lurbinectedin) and Roche's Tecentriq (atezolizumab) as a first-line...

Rocket Pharmaceuticals voluntarily withdrew its biologics license application with the FDA for its Fanconi anemia gene therapy RP-L102, following a corporate restructuring and prioritization of...

Scientists at the University of British Columbia have successfully performed the first human transplantation using a kidney enzymatically converted from blood type A to the universal type O. The...

Researchers leveraging generative artificial intelligence have identified new antimicrobial peptides effective against multidrug-resistant bacteria, addressing the critical challenge of antibiotic...

Biopharmaceutical companies recorded 62 layoff rounds in the third quarter of 2025, nearly matching the 64 rounds seen in each of the first two quarters, according to Fierce Biotech’s Layoff...

Pharmaceutical and computational biology sectors are embracing AI-driven innovations to accelerate drug discovery and molecular understanding. The OpenFold3 project marks a collaboration among...

Biopharma financings have totaled $47.1 billion from January through September 2025, marking a notable decline from $86.7 billion in the same period of 2024. This downturn is attributed mainly to...

Recent studies spotlight significant developments in pediatric and neonatal healthcare. Research reveals that COVID-19 vaccine boosters confer efficacy in immunosuppressed children, enhancing...

Cutting-edge research continues to unravel molecular pathways influencing cancer progression and immune response. Studies identify EZH2’s role in modulating T cell activation in hepatocellular...

Regulatory developments continue to shape pharmaceutical innovation and drug pricing frameworks. FDA leaders from CDER and CBER are scheduled to convene with BIO and PhRMA representatives to...

The U.S. FDA has granted priority approval for a first-line maintenance therapy combining Jazz Pharmaceuticals' Zepzelca (lurbinectedin) with Roche's Tecentriq (atezolizumab), or Tecentriq plus...

Pfizer has entered a 'most favored nation' drug pricing agreement with the U.S. government, establishing a precedent for presidential negotiation of pharmaceutical prices. While the deal leaves...

Researchers at the University of British Columbia have reported the first successful human transplant of a kidney enzymatically converted from blood type A to universal type O. This breakthrough...

Asabys Partners has integrated Aliath Bioventures in a $468 million strategic consolidation to build a life sciences investment platform exceeding $1.1 billion in assets under management by 2030....

Scientists from McMaster University and MIT have leveraged generative artificial intelligence to discover enterololin, a novel narrow-spectrum antibiotic targeting the Enterobacteriaceae family....

A study from the University of Pennsylvania reveals that a single dose of psilocybin rapidly and sustainably relieves pain hypersensitivity and anxiodepressive-like behaviors in chronic pain mouse...

Dovetail Genomics introduces LinkPrep, a novel assay enabling simultaneous reading of DNA sequence and spatial genome architecture. By capturing 3D genome folding patterns alongside genetic...

Splice Bio closed a $135 million Series B funding round to support its gene therapy pipeline aimed at treating rare genetic diseases. Leadership discussed strategic fundraising amid a challenging...

Rocket Pharmaceuticals has voluntarily withdrawn its Biologics License Application (BLA) for RP-L102, a gene therapy candidate targeting Fanconi anemia, following a corporate restructuring to...